Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related AXS
Will Hurricane Harvey Be The Costliest Storm The Insurance Industry's Ever Faced?
Earnings Scheduled For July 26, 2017
Related THRX
Theravance Inc Reports Prelim Tender Offer Results
Glaxosmithkline, Theravance Intend to File Relvar Ellipta for COPD in Japan

Analysts at Goldman Sachs downgraded Axis Capital Holdings (NYSE: AXS) from “neutral” to “sell.” The target price for Axis Capital has been lowered from $44 to $43. Axis Capital's shares closed at $46.34 yesterday.

Stifel Nicolaus downgraded Theravance (NASDAQ: THRX) from “buy” to “hold” and removed the price target of $37.86. Theravance's shares closed at $26.40 yesterday.

Sterne Agee downgraded SpringLeaf Holdings (NYSE: LEAF) from “buy” to “neutral.” The target price for SpringLeaf has been lowered from $30 to $28. SpringLeaf's shares closed at $26.49 yesterday.

Analysts at KeyBanc downgraded Computer Programs and Systems (NASDAQ: CPSI) from “hold” to “underweight.” The price target for Computer Programs is set to $55. Computer Programs' shares closed at $65.70 yesterday.

Latest Ratings for AXS

DateFirmActionFromTo
Oct 2017MKM PartnersMaintainsBuy
Oct 2017Bank of AmericaMaintainsBuy
Oct 2017CitigroupMaintainsNeutral

View More Analyst Ratings for AXS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPSI + AXS)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...